This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $30,011.90, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml volume. This is a firm fixed-price delivery order contract that runs through January 13, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,187.83, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. This is a firm-fixed-price delivery order contract with a completion date of January 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens (3 mL) and has a ceiling value of $86,270.93. It is a delivery order contract with a firm fixed-price pricing type, and the ultimate completion date is May 11, 2023.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $10,449.36 delivery order contract is for the supply of the medication Ozempic 0.25-0.5 mg/dose pen 3 mL and is a firm fixed price arrangement.
The contract has no set-aside designation and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,253.32, is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a completion date of December 27, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a $2,767.51 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for providing a comprehensive range of pharmaceutical and medical products to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pens. The $14,369.56 contract has a period of performance through July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract, valued at $9,254.29, is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price arrangement. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml. The contract has a ceiling value of $46,367.42 and is a firm fixed-price delivery order with a completion date of January 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $7,119.78, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The contract is a Delivery Order with a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of December 22, 2023....